Table 2.
Pathways enriched by differentially expressed genes (DEGs).
| Pathway | FDR | Genes in pathway | Number of common genes |
|---|---|---|---|
| Granulocyte Adhesion and Diapedesis | 6.09E-11 | 163 | 4 |
| EIF2 Signaling | 2.88E-10 | 173 | 6 |
| Atherosclerosis Signaling | 1.32E-07 | 119 | 1 |
| Hepatic Fibrosis / Hepatic Stellate Cell Activation | 1.66E-07 | 137 | 2 |
| LXR/RXR Activation | 1.78E-07 | 121 | 1 |
| T Helper Cell Differentiation | 2.91E-06 | 62 | 3 |
| Bladder Cancer Signaling | 5.83E-06 | 86 | 5 |
| Role of Macrophages | 2.23E-05 | 282 | 4 |
| Complement System | 4.96E-05 | 32 | 3 |
| Altered T Cell and B Cell Signaling in Rheumatoid Arthritis | 6.80E-05 | 76 | 2 |
| IL-8 Signaling | 6.96E-05 | 183 | 1 |
| PI3K Signaling in B Lymphocytes | 1.01E-04 | 122 | 3 |
| Regulation of the Epithelial-Mesenchymal Transition Pathway | 1.17E-04 | 175 | 1 |
| Neuroprotective Role of THOP1 in Alzheimer's Disease | 3.38E-04 | 40 | 1 |
| Role of Osteoblasts | 5.18E-04 | 214 | 2 |
| Acute Myeloid Leukemia Signaling | 5.48E-04 | 76 | 3 |
| ILK Signaling | 7.71E-04 | 181 | 2 |
| Macropinocytosis Signaling | 8.53E-04 | 68 | 2 |
| LPS/IL-1 Mediated Inhibition of RXR Function | 9.14E-04 | 210 | 2 |
FDR, false discovery rate; common gene, the overlap between DEGs and genes in the pathway.